Company
SingaporeNovartis Singapore Pharmaceutical Manufacturing Pte., Singapore, Singapore – FDA Inspections
Inspection records and compliance data for Novartis Singapore Pharmaceutical Manufacturing Pte. in Singapore. 1 FDA inspection on record, last inspected March 03, 2023.
Company Profile
This profile covers Novartis Singapore Pharmaceutical Manufacturing Pte. based in Singapore, Singapore.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected March 3, 2023.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 3, 2023 | NAI | Human Drugs · Drug Quality Assurance | 1202885 |
FDA documents
Form 483s (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
PharmaEssentia Corporation, Taichung Plant
FUJIFILM Diosynth Biotechnologies Texas, LLC
KBI Biopharma, Inc.
Chugai Pharma Manufacturing Co. Ltd. (CPMC)
Kyowa Kirin Co., Ltd.
Zydus Lifesciences Limited
Regeneron Ireland Designated Activity Company
ANTHEM BIOSCIENCES PRIVATE LIMITED - Phase II
ABC Pharmaceuticals
WuXi Biologics Ireland Limited
Company Information
Name
Novartis Singapore Pharmaceutical Manufacturing Pte.
FEI Number
3012958979
Address
8 Tuas Bay Lane, Singapore, Singapore
Country
Singapore
ID: fb15a25e-3d5c-408e-92a9-ba4b0906f449